Is a bird flu vaccine for chickens coming soon?
Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.
As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.
Canada purchases 500,000 doses of GSK's vaccine for bird flu
The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most at risk of being exposed to the virus through animals infected with avian influenza.
Zoetis gets Conditional License for Bird Flu Vaccine
Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.
As more people are hospitalized with bird flu, here's what's going on with vaccines for humans
As bird flu cases continue to pop up in humans, Canada announced Wednesday that it purchased 500,000 doses of vaccine targeted at the virus. Here’s what you need to know about bird flu vaccinations in the U.
Zoetis Inc. stock underperforms Friday when compared to competitors despite daily gains
This was the stock's third consecutive day of gains.
Hosted on MSN23m
Greenwich Academy's 2025 commencement speaker is the CEO of animal health company Zoetis
GREENWICH — Greenwich Academy's 2025 commencement speaker is alumna Kristin Coveny Peck, the CEO of animal health company Zoetis. Peck graduated from Greenwich Academy in 1989. She became the ...
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Why Zoetis Stock Took Another Tumble Today
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Yahoo Finance3d
Zoetis to Participate in Upcoming Investor Conferences
PARSIPPANY, N.J., February 20, 2025--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences.
Zoetis price target lowered to $200 from $225 at BTIG
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Morningstar1d
Zoetis Inc Class A ZTS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Why Zoetis Stock Was Falling Today
Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...